ABK Biomedical
  • Home
  • Who We Are
    • Senior Management
    • Board of Directors
    • Clinical Advisory Board
  • Products
  • Investors
  • Radiopacity
  • News & Events Blog
  • Contact Us

Publications

 S. Kehoe, N. Kilcup, R. Abraham, D. Boyd. Glass materials in interventional radiology and interventional oncology, In A.R. Boccaccini, D.S. Brauer, L. Hupa (Eds.), Bioactive Glasses: Fundamental, Technology and Applications, Royal Society of Chemistry, 2016. pISBN 9781782621690, eISBN 9781782622017.

S. Kehoe, S. Amensag, M. Looney, R.J. Abraham, D. Boyd. "Imageable" zinc-silicate glass microspheres for transarterial embolization: A renal artery embolization study. Biomedical Glasses 1, 2015, 70-79. 10.1515/bglass-201500007.

S. Kehoe, M. Looney, N. Kilcup, E. Tonkopi, C. Daly, R.J. Abraham, D. Boyd. Effects of γ-irradiation and accelerated aging on composition-structure-property relationships for radiopaque embolic microspheres. Journal of Non-Crystalline Solids 402, 2014, 84-90. 10.1016/j.jnoncrysol.2014.05.016.

M.S. Hasan, S. Kehoe, D. Boyd. Temporal analysis of dissolution by-products and genotoxic potential of spherical Zn-Si Bioglass: “Imageable beads” for transarterial Embolization 29, 2014, 566-581. Journal of Biomaterial's Applications. 10.1177/0885328214537694.

S. Kehoe, M.L. Tremblay, A. Coughlan, M.R. Towler, J. Rainey, R.J. Abraham, and D. Boyd. Preliminary investigation of the dissolution behavior, cytocompatibility, effects of fibrinogen conformation and platelet adhesion for radiopaque embolic particles, Journal of Functional Biomaterials 4, 2013, 89-113. doi:10.3390/jfb4030089.

S. Kehoe, M. Langman, U. Zwanziger, R.J. Abraham, D. Boyd. Mixture designs to assess composition-structure-property relationships in SiO2-CaO-ZnO-La2O3-TiO2-MgO-SrO-Na2O glasses: Potential materials for embolization. Journal of Biomaterial Applications 28, 2013, 416-33, 2013. doi: 10.1177/0885328212455834.

S. Kehoe, E. Tonkopi, R.J. Abraham, D. Boyd. Predicting the thermal responses and radiopacity of multicomponent zinc-silicate glasses: A focus on ZnO, La2O3, SiO2 and TiO2, Journal of Non-Crystalline Solids 358, 2012, 3388–3395. doi.org/10.1016/j.jnoncrysol.2012.08.024.

S. Kehoe, N. Kilcup, D. Boyd. Evaluation of cytotoxicity for novel composite embolic microspheres: Material optimization by response surface methodology, Materials Letters 86, 2012, 13-17. doi.org/10.1016/j.matlet.2012.06.087.



Conference Proceedings

S. Kehoe, R.J. Abraham, A. Bigot, D. Boyd, J. El-Khazen Dupuis, F. Michaud, G.P. Soulez. Multi-Modal "Imageable" Embolic Microspheres: A Preliminary Study on Occlusion Effectiveness, Level of Occlusion and Arterial Distribution in a Swine Liver Model, Washington, DC, March 4th - 9th, 2017. 

K.D. Brewer, C. Davis, X.F. Zhang, J. Fraser, F. Heelan, E. Tonkopi, P. Casey, C. Brown, S. Kehoe , D. Boyd, R. Abraham. Multimodal Imaging of Novel Embolic Microspheres for Transarterial Embolization in New Zealand White Rabbits, World Molecular Imaging Congress (WMIC) 2016, New York City, NY, September 7th -10th, 2016.  

S. Kehoe, S. Amensag, X.F. Zhang, S.C. Goodwin, R.J. Lewandowski, D. Liu, D. Boyd, R.J. Abraham. A Bilateral Partial Swine Renal Artery Embolization Study using “Imageable” Embolic Microspheres: Assessment of Mechanism of Occlusion, Embolization Effectiveness, Device Migration and Safety. Society of Interventional Radiology (SIR) 2016 Annual Meeting, Vancouver, BC, April 2 - 7, 2016.

S. Kehoe, R.J. Abraham, D. Boyd. Unilateral renal artery embolization in yucutan miniswine with imageable embolic microspheres. Society of Interventional Radiology, Atlanta, GA, February 28th - March 5th, 2015. Published in a supplement of the Journal of Vascular Interventional Radiology, 26(2), S79-80, doi.org/10.1016/j.jvir.2014.12.221

R.J. Abraham, H. Basseri, C. Davis, E. Tonkopi, S. Kehoe, D. Boyd, C. Bowen. Magnetic resonance imaging characteristics of imageable embolic microspheres. Society of Interventional Radiology, Atlanta, GA, February 28th - March 5th, 2015.  Published in a supplement of the Journal of Vascular Interventional Radiology, 26(2), S80, doi.org/10.1016/j.jvir.2014.12.222

M.S. Hasan, S. Kehoe, D. Boyd. Temporal analysis of dissolution by-products and genotoxic potential of spherical Zn-Si bioglass: “Imageable beads” for transarterial embolization. European Society of Biomaterials 2014, Liverpool, August 31- September 3, 2014.  
S. Kehoe, R.J. Abraham, C. Daly, D. Boyd. A pilot renal artery embolization study: Evaluation of “Imageable” embolic microspheres using hybrid (landrace yorkshire) farm pigs. European Society of Biomaterials 2014, Liverpool, August 31- September 3, 2014.

R.J. Abraham, S. Kehoe, C. Daly, D. Boyd. Deliverability, efficacy of occlusion and acute histopathological evaluation of novel radiopaque embolic microspheres (OccluRad) in a rabbit auricular artery model. Submitted to the Cardiovascular and Interventional Radiological Society of Europe meeting 2014, Glasgow, September 13-17, 2014.

S. Kehoe, R.J. Abraham, D. Boyd, In-Vitro and In-Vivo evaluation of a novel radio-opaque embolic agent, European Society of Biomaterials 2013, Madrid, September 8 -12, 2013.

S. Kehoe, D. Boyd, Examining the thermal characteristics and cytocompatibity of La-doped zinc-silicate embolic agents, Innovations in Biomedical Materials 2012, Raleigh, NC, September 10-13, 2012. 

S. Kehoe, R.J. Abraham, D. Boyd, An examination of compositional dependencies for novel embolic agents: An evaluation of dissolution by-products, 9th World Biomaterial’s Congress China, June 1-5, 2012. 

S. Kehoe, R.J. Abraham, E. Tonkopi, D. Boyd, Novel radiopaque embolic agent for uterine fibroid embolization: Determination of radiopacity and biological evaluation; cytocompatibility, intracutaneous reactivity and local effects after implantation, Society of Interventional Radiology (SIR) 2012 Annual Meeting, San Francisco, CA, March 24-29, 2012. Published in a supplement of the Journal of Vascular Interventional Radiology, 23(3), S33, doi.org/10.1016/j.jvir.2011.12.113

ABK Biomedical Inc. provides and continues to provide accurate information on its website. However, ABK Biomedical Inc. assumes no responsibility for accuracy and/or completeness, express or implied, as to the information contained or omitted and/or the products described. Furthermore, ABK Biomedical may change the products mentioned at any time without notice. At this time, ABK Biomedical Inc. products are not intended or approved for clinical use.
​

(C) Copyright 2016 - All International Rights Reserved - ABK Biomedical Inc.                                                                                                   
  • Home
  • Who We Are
    • Senior Management
    • Board of Directors
    • Clinical Advisory Board
  • Products
  • Investors
  • Radiopacity
  • News & Events Blog
  • Contact Us